MedAdNews: Which Color is it?

In this article, Karl Kraft, VP, marketing operations and med/reg/legal, TGaS® Advisors, commented on a Journal of General Internal Medicine article on DTC, in which the study suggests that adding a bit of heft to the medical/regulatory/legal review team may be in order.

Read in MedAdNews.

“The results of this study suggest a gap in the interpretation of FDA guidelines for DTC advertising. Moving forward, organizations will need to ensure the right people and processes are in place to deliver both effective and FDA compliant DTC ads,” says Karl Kraft, VP, marketing operations and med/reg/legal, TGaS® Advisors.

Karl Kraft, TGaS® Advisors

See all Publications posts